Lynn A. Tetrault - 11 Jun 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
Lynn A. Tetrault
Issuer symbol
NEO
Transactions as of
11 Jun 2021
Net transactions value
+$12,654
Form type
4
Filing time
14 Jun 2021, 17:07:55 UTC
Previous filing
11 Jun 2021
Next filing
13 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $12,654 +1,389 +4.1% $9.11 34,939 11 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Options Exercise $0 -1,389 -100% $0.000000* 0 11 Jun 2021 Common Stock 1,389 $9.11 Direct F1
holding NEO Stock Option (Right to Buy) 3,334 11 Jun 2021 Common Stock 3,334 $7.27 Direct F2
holding NEO Stock Options (Right to Buy) 1,507 11 Jun 2021 Common Stock 1,507 $11.60 Direct
holding NEO Stock Option (Right to Buy) 2,136 11 Jun 2021 Common Stock 2,136 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 11 Jun 2021 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 11 Jun 2021 Common Stock 3,714 $40.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 28, 2016, Lynn Tetrault was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F2 On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.